BDMT Global

About BDMT Global

BDMT Global is led by an award-winning team of commercialization experts, combining outsourced business development (BD) and marketing transformation (MT) skills and know-how to provide complete end-to-end solutions for companies navigating the complex U.S. market landscape. BDMT solves a major point of failure for global innovators: securing market approval. We achieve this through our Market Approval Starter-Scaler (MASS) solutions, a proven framework that provides strategic shortcuts for companies in life sciences, healthcare, technology, manufacturing, wellness, cosmeceuticals, robotics, IT, software, and other industries at the leading edge of innovation, to establish a U.S. presence, validate their technology, and accelerate growth. BDMT aims to bring Tomorrow’s Innovation Today (TINT) by bridging global companies with the U.S. ecosystem. One of our core initiatives is the DAC (Digitization, Automation, and Cross-Industry Collaboration) movement, launched in 2023 with Mayo Clinic as the inaugural sponsor. DAC was expanded in 2025 through our partnership with MEDevice Boston to launch the Innovator Summit, creating a powerful gateway for industry collaboration. We connect innovators directly with decision-makers through our built-in network of Key Opinion Leaders (KOLs), industry leaders, investors, and regulatory experts from renowned institutions, including Cleveland Clinic, CVS Pharmacy, Disher, Dragons and Angels, FundsnMotion, Johns Hopkins, MassRobotics, and Yale. Our approach combines market intelligence with deep relationship-building to create tailored pathways to market success. BDMT helps clients systematically de-risk their market entry, secure essential funding, accelerate time-to-market, and obtain market approval required to thrive in competitive U.S. sectors. From early-stage startups to established global companies, BDMT delivers the foundational setup and execution needed to transform innovation into commercial success.